We analyzed the frequency of single-nucleotide polymorphisms (SNPs) at positions À1053 (rs 2981572), 1380 (rs 2981573), 1462 (rs 2232360), and 3978 (rs 1518108) of the human interleukin-20 (IL-20) gene by tetraprimer ARMS-PCR method. A significant association between patients with psoriasis and the G allele at position À1053 (Po0.05) was established. The pairwise linkage disequilibrium (LD) matrix showed that the nearly complete LD was present within the polymorphisms at positions À1053, 1380, and 1462 of the IL-20 gene. We found that patients with plaque psoriasis had a higher frequency of the HT3 GAA haplotype (Po0.01, OR 2.341, 95% CI: 1.346-4.074) compared to the control group. Likewise, the HT3 GAA haplotype was associated with an increased risk of early-onset psoriasis (Po0.01, OR 2.305, 95% CI: 1.285-4.132), late onset of disease (Po0.01, OR 2.542, 95% CI: 1.266-5.102), familial psoriasis (Po0.02, OR 2.220, 95% CI: 1.249-3.945), and sporadic disease (Po0.01, OR 2.523, 95% CI: 1.390-4.580). Our data indicate that IL-20 gene polymorphisms should have a role in determining susceptibility to plaque-type psoriasis. The possible role of the studied SNPs in the regulation of the expression of IL-20 is unknown yet and needs further studies.
Introduction
Psoriasis is a multigenic cutaneous disorder characterized by keratinocyte hyperproliferation with hyper-and parakeratotic differentiation, epidermal influx of polymorphonuclear leukocytes, and the presence of a mononuclear infiltrate in the papillary dermis and in the epidermis. 1 Chronic plaque psoriasis is the type affecting approximately 90% of the patients with psoriasis and is the most common form in adults. 2 Several observations indicate that T cells and cytokines are of major importance in the pathogenesis of psoriasis. 3, 4 There is increasing evidence to suggest that the newly discovered cytokine interleukin-20 (IL-20) also has a role in the pathogenesis of cutaneous inflammation and in psoriasis. 5, 6 Cytokine IL-20 belongs to the IL-10 protein family, which includes additionally cytokines interleukin-10 (IL-10), interleukin-19 (IL-19), melanoma differentiation-associated antigen 7 (MDA-7), IL-10-related Tcell-derived inducible factor (IL-TIF), and AK-155. 7 The novel human IL-10-related molecule (IL-20) has been found to be preferentially expressed in monocytes and its main target is keratinocytes. 6, 8 Two receptor complexes (type I IL-20R and type II IL-20R) mediate an IL-20 response in keratinocytes. 9 The exposure of the cells to IL-20 induces translocation of STAT3 from the cytoplasm to the nucleus and stimulation of transcription from the STAT3-responsive reporter gene. 6 IL-20 appears to be the initiator of the signal in the epidermis that directly impacts on the keratinocytes to participate in the epidermal response to inflammation.
In the light of the above findings, the IL-20 gene appears to be very expedient for psoriasis studies. Together with the genes encoding IL-10, IL-19, and MDA-7, the IL-20 gene is found within a 200 kb region of chromosome 1 and they all comprise an IL-10 family cytokine cluster. 6, [10] [11] [12] Polymorphisms in cytokine IL-10 gene, single-nucleotide polymorphisms (SNPs), and microsatellites, located within the promoter and other regulatory regions, have extensively been investigated. [13] [14] [15] [16] Previous studies have presented evidence for an association between IL-10 SNPs with susceptibility to a number of autoimmune, malignant, and infectious diseases. Until now, the only study by Asadullah et al 17 have proved definitely that the IL-10 locus contributes to the susceptibility to psoriasis. In the present study, possible associations between IL-20 polymorphisms and psoriasis were assessed. We performed a haplotype analysis of the IL-20 SNPs, which enables us to assess the influence on the phenotype of the copresence of several variants of the same gene. To our knowledge, no polymorphism has been investigated, till now, in the IL-20 gene.
Results
We designed four sets of primers (Table 1) to apply tetraprimer ARMS-PCR by using the program at http:// cedar. genetics.soton.ac.uk/public-html/primer1.html. 18 After optimisation, we validated the specificity of all primer sets by direct sequencing using ABI Genetic Analyzer 310. Results of the tetraprimer ARMS-PCR were completely consistent with the results of the direct sequencing.
Genotype distributions for the four analyzed IL-20 gene polymorphisms had no deviation from HardyWeinberg equilibrium. We found that 71% of the control population had the allele T and 29% had the allele G at position À1053; 76% had the allele A and 24% had the allele G at position 1380; 75% had the allele A and 25% had the allele G at position 1462; and 54% had the allele T and 46% had the allele C at position 3978 in the IL-20 gene. On comparing psoriatic patients with controls, patients with plaque psoriasis had a higher frequency of the IL-20 À1053 G allele (Po0.05). We observed overrepresentation of the IL-20 À1053 G allele in patients with disease onset earlier than 40 years (Po0.05) and in patients with sporadic disease (Po0.05). The frequency of the IL-20 À1053 heterozygous T/G genotype was increased and the T/T genotype was decreased in psoriasis patients compared with controls, but the difference was not statistically significant (P ¼ 0.08) ( Table 2 ). The 1380 A/G and the 1462 A/G polymorphisms resulted in negative findings for both allele and genotype distributions when comparison between psoriatic patients and controls was performed (Tables 3 and  4) . Although there appeared to be fewer persons possessing the IL-20 1380 G/G homozygous genotype in the psoriasis group, the difference was not statistically significant (P ¼ 0.09) ( Table 3 ). Our results showed that the patients with psoriasis had a higher frequency of both T/T and C/C genotypes and a lower frequency of the heterozygous T/C genotype at position IL-20 3978 Table 7) . No significant association was observed concerning the other haplotypes.
Discussion
The results of the present study are the first demonstration of the association between IL-20 polymorphisms and psoriasis. IL-20 is the recently discovered cytokine, a member of IL-10 family of cytokines. Two lines of evidence suggest a role for IL-20 and its receptor complex in psoriasis. The first line of evidence for the role of IL-20 is that the the overexpression of IL-20 in transgenic mice induced lesions similar to those observed in psoriasis. 6 Blumberg et al 6 had demonstrated that the histological analysis of the skin of the IL-20 transgenic mice showed hyperkeratosis, thickened epidermis, and proliferation in the suprabasal layer resembling human psoriatic abnormalities. The immunohistochemical analysis of epidermal markers in transgenic mice observed the expression of the differentiation and proliferation markers in the suprabasal layers, which are normally confined to the basal layer. Castelijans et al 19 had observed similar immunohistochemical results in human psoriatic skin. These histological changes in the skin appear to be caused by circulating IL-20, because even mice expressing transgene in other tissues (liver) were similarly affected. 6 A second line of evidence implicating the role of IL-20 receptor complex in psoriasis is that both IL-20Ra and IL20Rb receptor subunits are markedly upregulated in human psoriatic skin compared to normal skin. 6 The upregulation of both IL-20 receptor subunit mRNAs is detected in keratinocytes as well as in endothelial cells and immune cells, the major cell types are considered to interact in psoriasis. Therefore, IL-20 may play a central role in the epidermal response to inflammation.
A clear relation between SNPs and microsatellites, located within the promoter region of the IL-10 gene and IL-10 cytokine expression levels, has been shown earlier.
13,14 IL-20 and its receptors are expressed in peripheral blood and probably that cytokine has systemic effects regulating the activity of immune response. Therefore, it would be reasonable to expect different expression levels of IL-20 related to different haplotypes. Supportive to this hypothesis is that we found significant relations only with the SNP located in the promoter area (position À1053). On comparing psoriatic patients with controls, patients with plaque psoriasis had a higher frequency of the IL-20 À1053 G allele (Po0.05). Moreover, the haplotype analysis revealed significantly higher frequency of the GAA haplotype in patients with psoriasis (Po0.01). The HT3 GAA haplotype identified to be associated with psoriasis is the haplotype also carrying the IL-20 À1053G variant. The G allele at position À1053 may induce more active expression of the IL-20. However, the differences between patients and controls were not highly significant and further investigations should be performed to confirm the effect of the GAA haplotype on the risk of psoriasis. We also do not have data as to how this haplotype influences the expression level of IL-20. Additional studies in this respect are needed.
Interestingly, the HT3 GAA haplotype is the only IL-20 haplotype from the major haplotypes carrying the G allele at the À1053 position and the A allele at the 1380 position. Our results showed that fewer persons had the IL-20 1380 G/G homozygous genotype in the psoriasis group. However, this difference between the psoriasis group and the control group was not reflected in the Pvalues. The G allele at position 1380 might reduce the risk of psoriasis, as the frequency of the HT2 GGG haplotype in psoriasis group was similar to that in controls. Further studies with large numbers of GG subjects would be warranted to support this evidence. In parallel to the GAA haplotype effect, studies of the effects of other described haplotypes (TAA; GGG; GAG; TGG) on the expression of IL-20 levels are needed.
In conclusion, estimating the haplotype-phenotype association, we found that the IL20 HT3 GAA haplotype was associated with an increased risk of psoriasis. Our data indicated that IL-20 gene polymorphisms could have a role in determining susceptibility to plaque-type psoriasis. However, the functional relevance of our findings should be investigated in further studies.
Materials and methods
Unrelated patients (n ¼ 254) with chronic plaque psoriasis from the Department of Dermatology, University of Tartu were divided into the subgroups according to the age of disease onset and family history of psoriasis. Patients with disease onset below the age of 40 years were assigned as early-onset psoriasis (n ¼ 180), while patients with onset of disease at the age of 40 and later years were referred to as the late-onset disease (n ¼ 74). The mean age at disease onset of the early-onset group was 20 years and the group included 94 male and 86 female subjects. The mean age at disease onset of the late-onset group was 53 years and the group included 41 male and 33 female patients. Patients were considered to have familial psoriasis if they had at least one first-or second-degree relative with psoriasis (n ¼ 101), or to have sporadic disease, if they had no affected relatives (n ¼ 153). Caucasian healthy volunteers, living in Estonia and free from the positive family history of psoriasis, served as a control group (n ¼ 148). The control group included 57 male and 91 female subjects. Individuals with a history of other dermatoses were not included in the control group. The study was approved by the Ethics Review Committee on Human Research of the University of Tartu.
In an initial study, a database search to find the SNPs at the IL-20 gene (reference sequence NT_021877) was performed. We chose the rs 2981572, rs 2981573, rs 2232360, and rs 1518108 because of the high variability and the validation statuses. In order to clarify the location of these SNPs in the IL-20 genomic region, their positions were defined as the number of nucleotides starting from initiation codon (ATG). The first polymorphism at position À1053 (rs 2981573) constitutes T/G substitution; the second at position 1380 (rs 2981573) is A/G substitution, the third at position 1462 is A/G substitution, and the fourth at position 3978 (rs 1518108) is T/C substitution.
Genomic DNA was extracted from the whole blood. We used standard protocol where at first cell lysis occurred, then the nuclei were lysed, and thereafter DNA was precipitated by ethanol. Formed precipitate was dissolved after washing DNA with 70% ethanol in Tris/ EDTA.
To detect the nucleotides at position À1053 (T or G), 1380 (A or G), 1462 (A or G), and 3978 (T or C), we applied novel tetraprimer ARMS-PCR method. 18 This method uses four different primers, two (so-called inner ones) are allele specific and two (outer ones) are control primers. The primers were designed by using the program at http://cedar.genetics.soton.ac.uk/publichtml/primer1.html. 18 The primers we used for SNP detection are shown in Table 1 . Each PCR reaction was carried out in total volume 20 ml, containing 100 ng of template DNA, 10 pmol of each inner primer, 1 pmol of each inner primer, 0.2 mM dNTP, and MgCl 2 according to Table 1 . The buffer and Taq polymerase (AmpliTaq DNA Polymerase, Applied Biosystems) were added according to the manufacturer's guidelines. For amplification, we applied a touchdown program: initial denaturation at 951C for 2 min followed by 10 cycles of 1 min denaturation at 951C, annealing at 101C higher than annealing temperature (Table 1) for 1 min (decreasing by 11C per cycle), and extension at 721C for 1 min. The following 25 cycles were performed at appropriate annealing temperature, followed by final extension at 721C for 10 min and storage at 41C. Agarose-gel electrophoresis (3%) was applied to analyze the PCR products.
To control the novel tetraprimer ARMS-PCR method and to validate the substitutions at positions À1053, 1380, 1462, and 3978, the sequencing of incidental DNA samples was performed and the results were compared to tetraprimer ARMS-PCR analysis issues. DNA from normal control individuals was amplified and PCR products sequenced directly on an ABI genetic analyzer 310.
Allele and genotype frequencies of IL-20 SNPs were calculated and compared between the psoriatic patients and the controls, using standard w 2 analysis. P-values were calculated for each variable. Significance was defined as a probability value less than 0.05. Pairwise LD was estimated by a log-linear model and the extent of disequilibrium was expressed in terms of standardized D 0 characteristic. The haplotype analysis was performed using maximum-likelihood method for estimating simultaneously haplotype frequencies and haplotypephenotype association as described in Tregouet et al. 
